Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Google Scholar citation report
Citations : 4859

Journal of Addiction Research & Therapy received 4859 citations as per Google Scholar report

Journal of Addiction Research & Therapy peer review process verified at publons
Indexed In
  • CAS Source Index (CASSI)
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • Academic Keys
  • JournalTOCs
  • SafetyLit
  • China National Knowledge Infrastructure (CNKI)
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • ICMJE
Share This Page

Xiaoying Xue

Xiaoying Xue

Xiaoying Xue
CHIEF PHYSICIAN, DIRECTOR,
Department of Radiotherapy
The Second Hospital of Hebei Medical University
China

Biography

Dr. Xue is engaged in the clinical and scientific research on non-surgical treatment such as radiotherapy and chemotherapy of cancer. The main research field is related to cancer’ radiotherapy, radiation biology, molecular biology. Dr.Xue is working on using various forms of radiation to detect and kill malignant cells. Ionizing radiation (IR) plays a major role in the treatment of patients with cancer. However, the efficacy of this therapeutic modality is often limited by the occurrence of radioresistance. Dr. Xue is very interested in translational medicine and also made a lot of efforts in translational medicine in the fields of radioresistance. Dr. Xue holds the view that it is of great value to find the molecular mechanism and a key mediator of the IR response as well as a potential target for circumventing IR resistance.

Research Interest

- The clinical research in the field of radiotherapy of cancer.
-The study on radiation biology of cancer.
-The study related to Central Nervous System Neoplasms.
- The study related to Prostate Cancer.

Certificate

Certificate
Relevant Topics
Top